Why Has Amphastar's Stock Taken a Drastic Turn This Year?

2 min read | January 02, 2025 07:54 PM AEDT | By Team Kalkine Media

Why Has Amphastar's Stock Taken a Drastic Turn This Year? — Image source: Shutterstock

Financial Health and Liquidity

The company's debt-to-equity ratio stands at 0.82, signifying a balanced capital structure. Amphastar Pharmaceuticals demonstrates strong liquidity, as evidenced by its current ratio of 3.43 and quick ratio of 2.61. These metrics reflect the company's ability to meet short-term obligations effectively and maintain operational stability.

Stock Trends and Valuation

Amphastar opened at $37.13 on Thursday, marking a notable position in the market. The stock's 50-day and 200-day simple moving averages of $44.50 and $44.38, respectively, highlight consistent performance over medium- and long-term periods. The company's price-to-earnings ratio of 12.38 and a price-to-earnings-growth ratio of 0.87 suggest alignment between its market valuation and growth metrics.

Market Range and Capitalization

Amphastar Pharmaceuticals has a 1-year low of $36.48 and a 1-year high of $65.92, showcasing variability in market dynamics over the period. With a market capitalization of $1.79 billion, the company maintains a competitive presence within its sector, reflecting its operational resilience and strategic positioning in the pharmaceutical industry.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.